The effects of monoamine oxidase inhibition and dopamine uptake blockade on MPTP-induced increase of 2-[3H]deoxyglucose uptake in specific mesencephalic catecholaminergic nuclei
- 1 April 1990
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 112 (1) , 7-13
- https://doi.org/10.1016/0304-3940(90)90313-x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Acute neuropathological changes in the caudate nucleus caused by MPTP and methamphetamine: Immunohistochemical studiesJournal of Neurocytology, 1990
- Neuropathological changes in the caudate nucleus elicited by MPTP and their prevention by monoamine oxidase inhibitionBrain Research, 1989
- VI. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the mouse: Relationships between monoamine oxidase, MPTP metabolism and neurotoxicityLife Sciences, 1985
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonismNature, 1984
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- Repeated administration of N-methyl-4-phenyl 1,2,5,6-tetrahydropyridine to rats is not toxic to striatal dopamine neuronesBiochemical Pharmacology, 1984
- Tritiated 2‐deoxy‐D‐glucose: A high‐resolution marker for autoradiographic localization of brain metabolismJournal of Comparative Neurology, 1984
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Quantitative measurement of local cerebral metabolic rate for glucose utilizing tritiated 2-deoxyglucoseBrain Research, 1981